FFA
TEVA icon

Farther Finance Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Farther Finance Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$488K Buy
14,418
+3,266
+29% +$109K ﹤0.01% 1577
2026
Q1 		$337K Buy
11,152
+1,468
+15% +$47.2K ﹤0.01% 1667
2025
Q4 		$302K Buy
9,684
+2,313
+31% +$57K ﹤0.01% 1640
2025
Q3 		$149K Buy
7,371
+749
+11% +$13.2K ﹤0.01% 1790
2025
Q2 		$111K Sell
6,622
-118
-2% -$1.9K ﹤0.01% 1708
2025
Q1 		$103K Buy
6,740
+148
+2% +$2.64K ﹤0.01% 1534
2024
Q4 		$145K Buy
6,592
+2,054
+45% +$37.4K 0.01% 1146
2024
Q3 		$81.8K Buy
4,538
+3,323
+273% +$58.2K ﹤0.01% 1402
2024
Q2 		$19.9K Sell
1,215
-160
-12% -$2.46K ﹤0.01% 1778
2024
Q1 		$19.1K Buy
1,375
+9
+0.7% +$113 ﹤0.01% 1507
2023
Q4 		$14.3K Buy
1,366
+963
+239% +$8.99K ﹤0.01% 1454
2023
Q3 		$4.11K Buy
403
+52
+15% +$484 ﹤0.01% 1583
2023
Q2 		$2.64K Buy
351
+156
+80% +$1.26K ﹤0.01% 1658
2023
Q1 		$1.73K Hold
195
– – ﹤0.01% 1687
2022
Q4 		$1.78K Buy
+195
New +$1.7K ﹤0.01% 1493

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Farther Finance Advisors's TEVA Position: Q2 2026 in Review

Farther Finance Advisors increased its Teva Pharmaceuticals (TEVA) stake by 29% in Q2 2026, buying an estimated $109K and bringing the position to 14,418 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Farther Finance Advisors first reported a position in TEVA in Q4 2022 and has held it in 15 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Farther Finance Advisors held 14,418 shares of Teva Pharmaceuticals worth $488K as of Q2 2026.
  • Farther Finance Advisors bought 3,266 Teva Pharmaceuticals shares in Q2 2026, an estimated $109K.
  • Teva Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1577 holding.
  • Farther Finance Advisors first reported a position in Teva Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.